1. Home
  2. FEMY vs HCTI Comparison

FEMY vs HCTI Comparison

Compare FEMY & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • HCTI
  • Stock Information
  • Founded
  • FEMY 2004
  • HCTI 2020
  • Country
  • FEMY United States
  • HCTI United States
  • Employees
  • FEMY N/A
  • HCTI N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • HCTI Retail: Computer Software & Peripheral Equipment
  • Sector
  • FEMY Health Care
  • HCTI Technology
  • Exchange
  • FEMY Nasdaq
  • HCTI Nasdaq
  • Market Cap
  • FEMY 12.5M
  • HCTI 13.5M
  • IPO Year
  • FEMY 2021
  • HCTI 2021
  • Fundamental
  • Price
  • FEMY $0.36
  • HCTI $2.52
  • Analyst Decision
  • FEMY Strong Buy
  • HCTI
  • Analyst Count
  • FEMY 3
  • HCTI 0
  • Target Price
  • FEMY $7.33
  • HCTI N/A
  • AVG Volume (30 Days)
  • FEMY 2.9M
  • HCTI 621.8K
  • Earning Date
  • FEMY 11-11-2025
  • HCTI 11-13-2025
  • Dividend Yield
  • FEMY N/A
  • HCTI N/A
  • EPS Growth
  • FEMY N/A
  • HCTI N/A
  • EPS
  • FEMY N/A
  • HCTI N/A
  • Revenue
  • FEMY $1,887,016.00
  • HCTI $11,866,000.00
  • Revenue This Year
  • FEMY $103.55
  • HCTI N/A
  • Revenue Next Year
  • FEMY $148.13
  • HCTI N/A
  • P/E Ratio
  • FEMY N/A
  • HCTI N/A
  • Revenue Growth
  • FEMY 98.61
  • HCTI N/A
  • 52 Week Low
  • FEMY $0.31
  • HCTI $1.37
  • 52 Week High
  • FEMY $1.80
  • HCTI $473.10
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 28.31
  • HCTI 42.44
  • Support Level
  • FEMY $0.35
  • HCTI $2.40
  • Resistance Level
  • FEMY $0.40
  • HCTI $2.77
  • Average True Range (ATR)
  • FEMY 0.04
  • HCTI 0.20
  • MACD
  • FEMY 0.01
  • HCTI 0.20
  • Stochastic Oscillator
  • FEMY 5.20
  • HCTI 67.53

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

Share on Social Networks: